Abstract

Ruxolitinib: First JAK inhibitor to reach the market

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Phase 1b/2 Study of the Efficacy and Safety of Sonidegib (LDE225) in Combination with Ruxolitinib (INC424) in Patients with Myelofibrosis
Francisco Cervantes ... Florian H Heidel
Blood | VOL. 126
Francisco Cervantes, et. al.Francisco Cervantes ... Florian H Heidel
03 Dec 2015
Efficacy, Safety, and Confirmation of the Recommended Phase 2 Dose of Ruxolitinib Plus Panobinostat in Patients with Intermediate or High-Risk Myelofibrosis
Alessandro M Vannucchi ... Eibhlin Conneally
Blood | VOL. 124
Alessandro M Vannucchi, et. al.Alessandro M Vannucchi ... Eibhlin Conneally
06 Dec 2014
Treatment with Imetelstat Improves Myelofibrosis-Related Symptoms and Other Patient-Reported Outcomes in Patients with Relapsed or Refractory Higher-Risk Myelofibrosis
Ying Wan ... Faye Feller
Blood | VOL. 136
Ying Wan, et. al.Ying Wan ... Faye Feller
05 Nov 2020
Efficacy, Safety, and Confirmation of the Recommended Phase 2 Starting Dose of the Combination of Ruxolitinib (RUX) and Panobinostat (PAN) in Patients (Pts) with Myelofibrosis (MF)
Florian H Heidel ... Francesco Passamonti
Blood | VOL. 126
Florian H Heidel, et. al.Florian H Heidel ... Francesco Passamonti
03 Dec 2015
View more papers

More From: Pharmacy Today

Paper Title
Journal
Date
Author
Pharmacists increasing access to reproductive health care
Ashley H Meredith
Pharmacy Today | VOL. 28
Ashley H MeredithAshley H Meredith
01 Dec 2022
What additional medications might be best for patients taking metformin?
Johanna Taylor Katroscik
Pharmacy Today | VOL. 28
Johanna Taylor KatroscikJohanna Taylor Katroscik
01 Dec 2022
Pharmacists have future role in atrial fibrillation management
Loren Bonner
Pharmacy Today | VOL. 28
Loren BonnerLoren Bonner
01 Dec 2022
List of medication safety best practices grows in most recent update
Olivia C Welter
Pharmacy Today | VOL. 28
Olivia C WelterOlivia C Welter
01 Dec 2022
View more papers